Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Piroxicam and carboplatin in canine oral non-tonsillar squamous cell carcinoma
Squamous cell carcinomas of the oral mucosa are known to be very aggressive and often very frustrating in their therapy. Does this combination of carboplatin and piroxicam coming from human medicine offer better therapeutic results than the current therapies? At least the preliminary results seems to be promising!

Results of the treatment with a combination of carboplatin and piroxicam in seven dogs with advanced non-tonsillar oral squamous cell carcinoma (SCC) were retrospectively analysed.

This multi-agent protocol was well tolerated by all dogs and resulted in a complete regression of the tumour without additional surgery in four of seven patients.
Additional surgery was necessary to remove a metastatic lymph node in one dog and residual tumour in a second dog, which achieved a partial response following medical therapy.

Median follow-up for all the dogs was 534 days, while the time-to-recurrence, time-to-progression and overall survival for this group of patients have not yet been reached.

Our study, although limited in number of animals, suggests that this multiagent approach is a useful treatment option for oral non-tonsillar SCC in dogs and warrants wider application.



Source: de Vos, J. P., Burm, A. G. D., Focker, A. P., Boschloo, H., Karsijns, M. & van der Waal, I. (2005): Piroxicam and carboplatin as a combination treatment of canine oral non-tonsillar squamous cell carcinoma: a pilot study and a literature review of a canine model of human head and neck squamous cell carcinoma. In: Veterinary and Comparative Oncology 3 (1), 16-24.




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

In-hospital ECG versus 24-hour Holter in dogs with atrial fibrillationmembers
Atrial fibrillation is a potentially life-threatening condition which requires good management including good monitoring. The objective of this study was to determine if the in-clinic ECG-derived heart rate could predict the at-home Holter-derived 24-hour average heart rate (Holter24h), and whether it is useful to identify slow versus fast atrial fibrillation in dogs.

  • Novel radiation therapy for inoperable massive hepatocellular carcinoma members
  • Red blood cell storage lesion - an updatemembers
  • Coagulation abnormalities in dogs following severe acute traumamembers
  • Ultrasound-guided epidural access at the lumbo-sacral spacemembers
  • Thrombelastometry in dogs undergoing orthopedic surgerymembers
  • COX-2 inhibitors after phacoemulsification cataract removalmembers
  • First report of achromatopsia in related Labrador Retriever without CNGB3 mutations members
  • Acute kidney injury in severe sepsismembers
  • First description of orbital pneumatosis in a young catmembers
  • Serum antibodies to βA1-crystallin and cataract formation in Cocker spanielsmembers
  • Canine osteosarcoma cells and aurora kinase inhibitorsmembers
  • Long-term compassionate use of oclacitinib in dogs with allergic skin diseasemembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2013 VetContact GmbH
    All rights reserved